United Kingdom - Inggeris - MHRA (Medicines & Healthcare Products Regulatory Agency)

mylan - hydrochlorothiazide; irbesartan - tablet - 12.5mg ; 150mg

Kanada - Inggeris - Health Canada

mylan pharmaceuticals ulc - irbesartan - tablet - 75mg - irbesartan 75mg - angiotensin ii receptor antagonists

Kanada - Inggeris - Health Canada

mylan pharmaceuticals ulc - irbesartan - tablet - 300mg - irbesartan 300mg - angiotensin ii receptor antagonists

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - irbesartan (unii: j0e2756z7n) (irbesartan - unii:j0e2756z7n) - irbesartan 150 mg

United Kingdom - Inggeris - MHRA (Medicines & Healthcare Products Regulatory Agency)

mylan - irbesartan - tablet - 75mg

United Kingdom - Inggeris - MHRA (Medicines & Healthcare Products Regulatory Agency)

mylan - irbesartan - tablet - 150mg

United Kingdom - Inggeris - MHRA (Medicines & Healthcare Products Regulatory Agency)

mylan - irbesartan - tablet - 300mg

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - hydrochlorothiazide, quantity: 25 mg; irbesartan, quantity: 300 mg - tablet - excipient ingredients: microcrystalline cellulose; croscarmellose sodium; pregelatinised maize starch; colloidal anhydrous silica; magnesium stearate; sodium lauryl sulfate; povidone; lactose monohydrate; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; macrogol 3350; iron oxide black - abisart hct is indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

Ireland - Inggeris - HPRA (Health Products Regulatory Authority)

mcdermott laboratories ltd t/a gerard laboratories - irbesartan - tablets - 75 milligram

Ireland - Inggeris - HPRA (Health Products Regulatory Authority)

mcdermott laboratories ltd t/a gerard laboratories - irbesartan - tablets - 150 milligram